US Senators are currently in the midst of negotiation and finalizing a $10 billion coronavirus aid bill as they await analysis from the Congressional Budget Office. The package has garnered bipartisan support. The bill is expected to contribute to therapeutics including g vaccinations and will be set to reprogram the money that has been passed in previous coronavirus bills. However, the US contribution to global coronavirus efforts seems to be the continued area of contention, particularly the country’s role in raising vaccination rates in other countries. Therefore, as the discussions continue, we can expect debates on whether the money which is currently at the discretion of the Department of Health and Human Services should be re-allocated to the U.S. Agency for International Development instead. Read the full article here
Comments are closed.